Coronavirus: Commission proposes EU Strategy for the development and availability of therapeutics

(Credit: Unsplash)

This article is brought to you in association with the European Commission.


The European Commission is today complementing the successful EU Vaccines Strategy with a strategy on COVID-19 therapeutics to support the development and availability of much-needed COVID-19 therapeutics, including for the treatment of ‘long COVID’. Today’s Strategy covers the full lifecycle of medicines: from research, development and manufacturing to procurement and deployment.

It is part of the strong European Health Union, in which all EU countries prepare and respond together to health crises and ensure the availability of affordable and innovative medical supplies – including the therapeutics needed to treat COVID-19.

The Strategy includes clear actions and targets, including authorising three new therapeutics to treat COVID-19 by October 2021 and possibly two more by end of the year. Concretely:

  • Research, development and innovation
    • Invest €90 million in population studies and clinical trials to establish links between risk factors and health outcomes to further inform public health policy and clinical management, including for long-COVID patients.
    • Set up a ‘therapeutics innovation booster’ by July 2021 to support the most promising therapeutics from preclinical research to market authorisation. It will build on current initiatives and investments in therapeutic development, working in a close cooperation with the European Health Emergency Preparedness and Response Authority (HERA) preparatory action on mapping therapeutics. It will therefore ensure the coordination of all research projects on COVID-19 therapeutics, stimulating innovation and boosting therapeutic development.
  • Access to and swift approval of clinical trials
    • Invest €5 million under the EU4Health programme to generate better, high-quality safety data in clinical trials, which will help produce robust results in a timely manner.
    • Provide EU countries with financial support of €2 million under the EU4Health 2021 work programme for expedited and coordinated assessments to facilitate approval of clinical trials.
    • Explore how to support developers of therapeutics to build capacity to produce high-grade material for clinical trials.
  • Scanning for candidate therapeutics
    • Invest €5 million to map therapeutics and diagnostics to analyse development phases, production capacities and supply chains, including possible bottlenecks.
    • Establish a broader portfolio of 10 potential COVID-19 therapeutics and identify five of the most promising ones by June 2021.
  • Supply chains and delivery of medicines
    • Fund a €40 million preparatory action to support flexible manufacturing and access for COVID-19 therapeutics under the EU Fab project, which in turn will become over time an important asset for the future the European Health Emergency Preparedness and Response Authority (HERA).
  • Regulatory flexibility
    • Authorise at least three new therapeutics by October and possibly two more by the end of the year and develop flexible regulatory approaches to speed up the assessment of promising and safe COVID-19 therapeutics.
    • Start seven rolling reviews of promising therapeutics by end-2021, subject to research and development outcomes.
  • Joint procurement and financing
    • Launch new contracts for the purchase of authorised therapeutics by the end of the year.
    • Secure faster access to medicines with shorter administrative deadlines.
  • International cooperation to make medicines available to all
    • Reinforce engagement for the therapeutics pillar of the Access to COVID-19 Tools Accelerator.
    • Boost ‘OPEN’ initiative for international collaboration.

Next Steps

The Commission will draw up a portfolio of 10 potential COVID-19 therapeutics and by June 2021, identify the five most promising ones. It will organise matchmaking events for industrial actors involved in therapeutics to ensure enough production capacity and swift manufacturing. New authorisations, rolling reviews and joint procurement contracts will be up and running before the end of the year.

The therapeutics innovation booster, matchmaking events and preparatory action to support flexible manufacturing and access for COVID-19 therapeutics under the EU Fab project, will feed into the HERA, for which a proposal is due later in the year. The pilot project on access to health data will feed into the European Health Data Space proposal expected later this year.

Members of the College said:

Vice-President for Promoting our European Way of Life, Margaritis Schinas, said: The situation in many intensive care units across the continent remains critical. We need to focus both on vaccines and therapeutics, as two powerful and complementary ways to combat COVID-19. But currently we have only one authorised medicine to treat COVID-19. By acting on better availability of medicines today, we are making sure patients receive the treatments they need while also preparing our future biomedical preparedness. A coordinated strategy on quick access to therapeutics will boost our strategic autonomy and contribute to a strong Health Union.”

Commissioner for Health and Food Safety, Stella Kyriakides, said:“Vaccinations save lives, but they cannot yet eradicate COVID-19. We need a strong push on treatments to limit the need for hospitalisation, speed up recovery times, and reduce mortality. Patients in Europe and across the world should have access to world-class COVID-19 medicines. This is why we have set a very clear goal: by October, we will develop and authorise three new effective COVID-19 therapeutics that can have the potential to change the course of the disease. We will do so by investing in research and innovation, the identification of new promising medicines, ramping up production capacity and supporting equitable access. Our Therapeutics Strategy is a strong European Health Union in action.”

Commissioner for Innovation, Research, Culture, Education and Youth, Mariya Gabriel, said: “By increasing vaccine availability across Europe, more and more Europeans are now protected against COVID-19. In the meantime, the development of innovative medicines to treat coronavirus patients remains a priority when it comes to saving lives. Research and innovation is the first step to finding effective and safe therapeutics, which is why we are proposing to establish a new COVID-19 ‘therapeutics innovation booster’ and will invest € 90 million in population studies and clinical trials.

Background

The Strategy on COVID-19 therapeutics complements the EU strategy for COVID-19 vaccines from June 2020 and builds on ongoing work by the European Medicines Agency and the Commission to support research, development, manufacturing and deployment of therapeutics.

The Strategy forms part of a strong European Health Union, using a coordinated EU approach to better protect the health of our citizens, equip the EU and its Member States to better prevent and address future pandemics, and improve the resilience of Europe’s health systems.

the sting Milestones

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

European Commission increases support for the EU’s beekeeping sector

More protection for our seas and oceans is needed, report finds

Which country offers the cheapest mobile data?

INTERVIEW: ‘Defend the people, not the States’, says outgoing UN human rights chief

10 ways central banks are experimenting with blockchain

Can the US-Iran rapprochement change the world?

DR Congo elections: ‘historic opportunity’ for ‘peaceful transfer of power’ says Security Council

What can be done to avoid the risk of being among the 7 million that will be killed by air pollution in 2020?

Is there a de facto impossibility for the Brexit to kick-start?

How trust and collaboration are key in India’s last mile response to the COVID-19 crisis

Investors must travel a winding road to net-zero. Here’s a map

Engaging women and girls in science ‘vital’ for Sustainable Development Goals

‘No steps taken’ so far to end Israel’s illegal settlement activity on Palestinian land – UN envoy

In visit to hurricane-ravaged Bahamas, UN chief calls for greater action to address climate change

Illegal fishing plagues the Pacific Ocean. Here’s how to end it

How AI and machine learning are helping to fight COVID-19

EU tells Britain stay in as long as you wish

Financing fossil fuels risks a repeat of the 2008 crash. Here’s why

Here are 4 tips for governing by design in the Fourth Industrial Revolution

How curiosity and globalization are driving a new approach to travel

Coronavirus (COVID-19): truth and myth on personal risk perception

The battle for the 2016 EU Budget to shake the Union; Commission and Parliament vs. Germany

Innovation can transform the way we solve the world’s water challenges

#WorldBicycleDay: 5 benefits of cycling

Missile strike kills at least 12 civilians, including children, in Syria’s Idlib: UN humanitarians

4 steps to developing responsible AI

Mental health and suicide prevention – What can be done to increase access to mental health services in my region?

UN chief outlines ‘intertwined challenges’ of climate change, ocean health facing Pacific nations on the ‘frontline’

New US President: MEPs hope for a new dawn in transatlantic ties

Desires for national independence in Europe bound by economic realities

European Union and African Union sign partnership to scale up preparedness for health emergencies

Yemen war: UN chief urges good faith as ‘milestone’ talks get underway in Sweden

Spring 2019 Standard Eurobarometer: Europeans upbeat about the state of the European Union – best results in 5 years

Coronavirus: Commission approves contract with CureVac to ensure access to a potential vaccine

Outbreak of COVID-19: The third wave and the people

A day in the life of a Venezuelan migrant in Boa Vista, Brazil

EU Copyright Directive: Google News threatens to leave Europe while media startups increasingly worry

3 ways to fight short-termism and relaunch Europe

Accountability in Sudan ‘crucial’ to avoid ‘further bloodshed’, says UN rights office

UN committed ‘to support the Libyan people’ as Guterres departs ‘with deep concern and a heavy heart’

Antarctica: the final coronavirus-free frontier. But will it stay that way?

Mario Draghi didn’t do it but Kim Jong-un did

UN chief welcomes G20 commitment to fight climate change

MEPs: Access to adequate housing should be a fundamental European right

More countries are making progress on corruption – but there’s much to be done, says a new report

Mountains matter, especially if you’re young, UN declares

EU food watchdog: more transparency, better risk prevention

Young activists share four ways to create a more inclusive world

The European Sting @ the European Business Summit 2014 – Where European Business and Politics shape the future

More than one million sexually transmitted infections occur every day: WHO

These countries spend the most on education

How a new approach to meat can help end hunger

MEPs cap prices of calls within EU and approve emergency alert system

Electronic cigarettes: is it really a safe alternative to smoking?

China confirms anti-state-subsidy investigation on EU wine imports

Century challenge: inclusion of immigrants in the health system

Here’s how we reboot digital trade for the 21st century

Britain and Germany change attitude towards the European Union

UN, global health agencies sound alarm on drug-resistant infections; new recommendations to reduce ‘staggering number’ of future deaths

Ten new migratory species protected under global wildlife agreement

More Stings?

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s